TuHURA BIOSCIENCES, INC./NV Finite-Lived Intangible Assets, Period Increase (Decrease)
TuHURA BIOSCIENCES, INC./NV (HURA) reported Finite-Lived Intangible Assets, Period Increase (Decrease) of -$12.65 thousand for the 12-month period ending 2018-06-30, per its 10-K filed 2019-09-09.
Discontinued › Notes
us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease · last filed 2019-09-09
- TuHURA BIOSCIENCES, INC./NV finite-lived intangible assets, period increase (decrease) for the quarter ending 2018-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV finite-lived intangible assets, period increase (decrease) for the quarter ending 2016-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV finite-lived intangible assets, period increase (decrease) for fiscal 2018 was -$12.65K.
- TuHURA BIOSCIENCES, INC./NV finite-lived intangible assets, period increase (decrease) for fiscal 2016 was -$16.76K.
| Period end | Finite-Lived Intangible Assets, Period Increase (Decrease) 3 month | Finite-Lived Intangible Assets, Period Increase (Decrease) 9 month | Finite-Lived Intangible Assets, Period Increase (Decrease) 12 month |
|---|---|---|---|
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-09 | -$12.65K 10-K · filed 2019-09-09 | |
| 2018-03-31 | -$12.65K 10-Q · filed 2019-05-14 | ||
| 2017-06-30 | -$20.96K 8-K · filed 2019-06-03 | ||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | -$16.76K 10-K · filed 2017-09-27 | |
| 2016-03-31 | -$16.76K 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |